Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 37:562-568
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piippo, K.
Right arrow Articles by Kontula, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piippo, K.
Right arrow Articles by Kontula, K.

A founder mutation of the potassium channel KCNQ1 in long QT syndrome

Implications for estimation of disease prevalence and molecular diagnostics

Kirsi Piippo, MSc*, Heikki Swan, MD*, Michael Pasternack, PhD{dagger}, Hugh Chapman, PhD{dagger}, Kristian Paavonen, MD*, Matti Viitasalo, MD*, Lauri Toivonen, MD* and Kimmo Kontula, MD*

* Department of Medicine, University of Helsinki, Helsinki, Finland
{dagger} Institute of Biotechnology, University of Helsinki, Helsinki, Finland



View larger version (28K):

[in a new window]
 
Figure 1 Pedigrees of families 1012 and 1034. Squares represent males, circles are females and symbols with slash mark represent deceased subjects. Half-filled symbols indicate heterozygous KCNQ1-Fin carriers, filled symbols homozygous KCNQ1-Fin carriers and half-striped symbols are heterozygous Y171X carriers. Open symbols denote unaffected individuals verified by deoxyribonucleic acid (DNA) assay. Subjects IV/6 and IV/8 in family 1012 and III/7 in family 1034 have Jervell and Lange-Nielsen syndrome (JLNS). The QTc interval (ms) is shown under each symbol; those marked with an asterisk have been recorded during medication.

 


View larger version (24K):

[in a new window]
 
Figure 2 In vitro expression of the KCNQ1-Fin mutation in COS cells. (a) Whole-cell patch-clamp recordings from cells transfected with KCNQ1-wt + minK; (b) KCNQ1-wt + KCNQ1-Fin + minK; and (c) KCNQ1-Fin + minK. The relative activation curves obtained from the immediate tail are plotted in (d). The common voltage protocol used in these experiments is shown in (e).

 


View larger version (42K):

[in a new window]
 
Figure 3 Number of established male (hatched bars) and female (open bars) KCNQ1-Fin carriers according to their QTc interval classes, and percentage of symptomatic individuals in the same classes (males and females combined). None of the individuals included in this analysis had any medication at the moment of QTc measurement. QTc = QT interval corrected for heart rate according to Bazett’s formula.

 


View larger version (22K):

[in a new window]
 
Figure 4 Geographical distribution of ancestral KCNQ1-Fin carriers. Each spot on the map represents the earliest recognized KCNQ1-Fin carrier of the affected family (n = 34). The early immigration probably took place from the east and the late immigration from the south and west. A major internal movement started in the sixteenth century from southeastern Finland toward the western and northern parts of the country.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement